Back to search
FDAFDA · Food and drugs·Recall number Z-0954-2022

Inactivated macrolide and quinolone-resistant Mycoplasma genitalium

Published April 27, 2022 · Recall initiated: March 24, 2022

Summary

FDA records medical device Class II recall Z-0954-2022, published April 27, 2022 and initiated March 24, 2022. Recalling firm: Microbiologics Inc; Status: Terminated; Reported quantity: 1 ea; Lot: Catalog HE0069N; Lot HE0069-02-1 UDI: 10845357043990. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

QC process was not adequate for the specification range.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Microbiologics Inc
Distributor
US Nationwide distribution in the state of TX.
Lot
Catalog HE0069N; Lot HE0069-02-1 UDI: 10845357043990
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Inactivated macrolide and quinolone-resistant Mycoplasma genitalium recalled?

Yes. FDA published recall Z-0954-2022 on April 27, 2022. Reported hazard: QC process was not adequate for the specification range.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail